Follow
EF. Smit
EF. Smit
Hoogleraar longziekten
Verified email at nki.nl
Title
Cited by
Cited by
Year
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small-cell lung cancer
M Fukuoka, S Yano, G Giaccone, T Tamura, K Nakagawa, JY Douillard, ...
Journal of clinical oncology 21 (12), 2237-2246, 2003
39552003
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
35812014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D Planchard, ST Popat, K Kerr, S Novello, EF Smit, C Faivre-Finn, TS Mok, ...
Annals of Oncology 29, iv192-iv237, 2018
2394*2018
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The lancet oncology 16 (6), 630-637, 2015
15692015
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label …
L Paz-Ares, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ...
The Lancet 394 (10212), 1929-1939, 2019
15462019
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ...
Nature genetics 44 (10), 1104-1110, 2012
14662012
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
H Van Tinteren, OS Hoekstra, EF Smit, JHAM Van Den Bergh, ...
The Lancet 359 (9315), 1388-1392, 2002
10332002
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer
J Weiss, ML Sos, D Seidel, M Peifer, T Zander, JM Heuckmann, RT Ullrich, ...
Science translational medicine 2 (62), 62ra93-62ra93, 2010
10082010
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
D Planchard, EF Smit, HJM Groen, J Mazieres, B Besse, Ĺ Helland, ...
The Lancet Oncology 18 (10), 1307-1316, 2017
9072017
RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics
MG Best, N Sol, I Kooi, J Tannous, BA Westerman, F Rustenburg, ...
Cancer cell 28 (5), 666-676, 2015
8332015
Pan-cancer whole-genome analyses of metastatic solid tumours
P Priestley, J Baber, MP Lolkema, N Steeghs, E de Bruijn, C Shale, ...
Nature 575 (7781), 210-216, 2019
8192019
Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids
KK Dijkstra, CM Cattaneo, F Weeber, M Chalabi, J van de Haar, ...
Cell 174 (6), 1586-1598. e12, 2018
7992018
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer
JP Van Meerbeeck, GWPM Kramer, PEY Van Schil, C Legrand, EF Smit, ...
Journal of the National Cancer Institute 99 (6), 442-450, 2007
7862007
Long‐term expanding human airway organoids for disease modeling
N Sachs, A Papaspyropoulos, DD Zomer‐van Ommen, I Heo, L Böttinger, ...
The EMBO journal 38 (4), e100300, 2019
7772019
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
J Wolf, T Seto, JY Han, N Reguart, EB Garon, HJM Groen, DSW Tan, ...
New England Journal of Medicine 383 (10), 944-957, 2020
7142020
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
PK Paik, E Felip, R Veillon, H Sakai, AB Cortot, MC Garassino, J Mazieres, ...
New England Journal of Medicine 383 (10), 931-943, 2020
6522020
Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase–positive non–small-cell lung cancer: a randomized, multicenter phase II trial
DW Kim, M Tiseo, MJ Ahn, KL Reckamp, KH Hansen, SW Kim, RM Huber, ...
Journal of Clinical Oncology 35 (22), 2490-2498, 2017
6372017
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer
FJ Lagerwaard, CJA Haasbeek, EF Smit, BJ Slotman, S Senan
International Journal of Radiation Oncology* Biology* Physics 70 (3), 685-692, 2008
6182008
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
BT Li, EF Smit, Y Goto, K Nakagawa, H Udagawa, J Mazičres, ...
New England Journal of Medicine 386 (3), 241-251, 2022
5602022
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
5382014
The system can't perform the operation now. Try again later.
Articles 1–20